Susan Night Email

VP, Site Engagement and Network Strategy . Translational Drug Development

Scottsdale, AZ

Location

s*****@td2inc.com

Primary Email

Current Roles

Employees:
173
Revenue:
$34.8M
About
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families.\n\nTD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGenâ??s deep scientific expertise and approach to interrogating the â??omicâ?? drivers of disease is at the heart of TD2â??s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.
Translational Drug Development Address
13208 E Shea Blvd. Suite 100
Scottsdale, AZ
United States
Translational Drug Development Email
Translational Drug Development Phone Numbers
602-358-8300

Past Companies

Translational Drug Development (TD2)Vice President, Site Engagement and Network Strategy
McKesson Specialty Health, US Oncology ResearchDirector, Research Optimization
McKesson Specialty HealthManager Research Site Services

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.